CN100484518C - 药物剂量逐渐增加的剂型 - Google Patents

药物剂量逐渐增加的剂型 Download PDF

Info

Publication number
CN100484518C
CN100484518C CNB97197439XA CN97197439A CN100484518C CN 100484518 C CN100484518 C CN 100484518C CN B97197439X A CNB97197439X A CN B97197439XA CN 97197439 A CN97197439 A CN 97197439A CN 100484518 C CN100484518 C CN 100484518C
Authority
CN
China
Prior art keywords
layer
drug
dosage form
molecular weight
average molecular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB97197439XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1228691A (zh
Inventor
P·施瓦纳德
A·D·阿耶
J·D·威里格特
A·拉穆
L·G·哈默尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21814183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN100484518(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of CN1228691A publication Critical patent/CN1228691A/zh
Application granted granted Critical
Publication of CN100484518C publication Critical patent/CN100484518C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
CNB97197439XA 1996-08-16 1997-08-08 药物剂量逐渐增加的剂型 Expired - Lifetime CN100484518C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2328696P 1996-08-16 1996-08-16
US60/023,286 1996-08-16

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN200910129895.8A Division CN101518517B (zh) 1996-08-16 1997-08-08 药物剂量逐渐增加的剂型

Publications (2)

Publication Number Publication Date
CN1228691A CN1228691A (zh) 1999-09-15
CN100484518C true CN100484518C (zh) 2009-05-06

Family

ID=21814183

Family Applications (2)

Application Number Title Priority Date Filing Date
CNB97197439XA Expired - Lifetime CN100484518C (zh) 1996-08-16 1997-08-08 药物剂量逐渐增加的剂型
CN200910129895.8A Expired - Lifetime CN101518517B (zh) 1996-08-16 1997-08-08 药物剂量逐渐增加的剂型

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN200910129895.8A Expired - Lifetime CN101518517B (zh) 1996-08-16 1997-08-08 药物剂量逐渐增加的剂型

Country Status (13)

Country Link
EP (1) EP0957899B1 (enExample)
JP (1) JP4393587B2 (enExample)
CN (2) CN100484518C (enExample)
AT (1) ATE234602T1 (enExample)
AU (1) AU3909597A (enExample)
CA (1) CA2263558A1 (enExample)
CY (1) CY2475B1 (enExample)
DE (1) DE69720055T2 (enExample)
DK (1) DK0957899T3 (enExample)
ES (1) ES2194210T3 (enExample)
PT (1) PT957899E (enExample)
WO (1) WO1998006380A2 (enExample)
ZA (1) ZA977254B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
EP1690531A3 (en) * 1996-09-30 2010-01-20 Alza Corporation Dosage form and method for administering drug
EP0932388B1 (en) * 1996-09-30 2006-03-29 Alza Corporation Dosage form and method for administering drug
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
CN1182839C (zh) * 1996-11-25 2005-01-05 阿尔萨公司 递增剂量的剂型
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
DE69920689T2 (de) * 1998-06-03 2005-02-24 Alza Corp., Mountain View Vorrichtungen zum Aufrechterhalten eines gewünschten therapeutischen Medikamenteneffekts über einen verlängerten Therapiezeitraum
AU2012232984B2 (en) * 1998-06-03 2015-10-29 Alza Corporation Methods and devices for providing prolonged drug therapy
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
KR100890537B1 (ko) * 1998-06-03 2009-03-27 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
AU2004200938B2 (en) * 1998-06-03 2006-09-14 Alza Corporation Methods and devices for providing prolonged drug therapy
HU230454B1 (hu) 1998-11-02 2016-07-28 Alkermes Pharma Ireland Limited Metilfenidátot tartalmazó módosított felszabadulású sokszemcsés készítmény
US6673367B1 (en) * 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6217904B1 (en) 1999-04-06 2001-04-17 Pharmaquest Ltd. Pharmaceutical dosage form for pulsatile delivery of d-threo-methylphenidate and a second CNS stimulant
JP2004508278A (ja) * 2000-01-20 2004-03-18 デルシス　ファーマシューティカル　コーポレイション 多段薬物投与形態
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
CA2494234C (en) * 2002-07-29 2009-10-27 Alza Corporation Methods and dosage forms for controlled delivery of paliperidone
JP2006507305A (ja) * 2002-10-31 2006-03-02 アルザ・コーポレーシヨン 液体製剤の上昇型放出を提供する剤形
US7988993B2 (en) 2002-12-09 2011-08-02 Andrx Pharmaceuticals, Inc. Oral controlled release dosage form
EP2184058B1 (en) 2003-09-26 2012-02-08 ALZA Corporation Drug coating providing high drug loading and methods for providing the same
US20070259033A1 (en) * 2003-09-26 2007-11-08 Evangeline Cruz Controlled release formulations exhibiting an ascending rate of release
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
WO2015001488A1 (en) 2013-07-01 2015-01-08 Ranbaxy Laboratories Limited Extended-release tablets of paliperidone and processes of preparation thereof
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
MX2018007977A (es) * 2015-12-31 2018-11-09 Cadila Healthcare Ltd Forma farmaceutica osmotica de liberacion extendida que contiene una carga de clorhidrato de metilfenidato alta.
EP3501504A1 (en) 2017-12-22 2019-06-26 Pharmacia Polonica sp. z o.o. Modified release tablet of paliperidone and a process for the preparation thereof
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4915954A (en) * 1987-09-03 1990-04-10 Alza Corporation Dosage form for delivering a drug at two different rates
US5017381A (en) * 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery

Also Published As

Publication number Publication date
ATE234602T1 (de) 2003-04-15
DK0957899T3 (da) 2003-04-22
ES2194210T3 (es) 2003-11-16
WO1998006380A3 (en) 1998-05-14
AU3909597A (en) 1998-03-06
EP0957899A2 (en) 1999-11-24
JP4393587B2 (ja) 2010-01-06
ZA977254B (en) 1998-05-11
CN101518517A (zh) 2009-09-02
PT957899E (pt) 2003-07-31
HK1137355A1 (zh) 2010-07-30
CN101518517B (zh) 2014-11-26
CN1228691A (zh) 1999-09-15
DE69720055T2 (de) 2003-09-11
DE69720055D1 (de) 2003-04-24
JP2000516610A (ja) 2000-12-12
HK1021886A1 (zh) 2000-07-14
EP0957899B1 (en) 2003-03-19
WO1998006380A2 (en) 1998-02-19
CY2475B1 (en) 2005-06-03
CA2263558A1 (en) 1998-02-19

Similar Documents

Publication Publication Date Title
CN100484518C (zh) 药物剂量逐渐增加的剂型
JP5215347B2 (ja) 上昇する投与量の薬剤投与型
CA2041579C (en) Dosage form
AU685297B2 (en) Tacrine pharmaceutical compositions
US5091190A (en) Delivery system for administration blood-glucose lowering drug
US5192550A (en) Dosage form for treating central nervous system disorders
JPS62267221A (ja) 新規薬物製剤
JPH09512550A (ja) 抗癲癇薬の効果的な投与形態
USRE44459E1 (en) Method for lowering blood glucose
JP2590226B2 (ja) ジルチアゼム投与用投薬形態
EP1782798A2 (en) Ascending-dose dosage form
JP2002514592A (ja) 抗うつ剤療法
HK1137355B (en) Dosage form for providing ascending dose of drug
HK1021886B (en) Dosage form for providing ascending dose of drug
HK1103653A (en) Ascending-dose dosage form
HK1021620B (en) Ascending-dose dosage form
CN112741815A (zh) 一种新型抗抑郁缓控释给药系统
US20040062799A1 (en) Therapeutic composition and delivery system for administering drug
CN112741806A (zh) 一种用于老年痴呆症的缓控释给药系统

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1021886

Country of ref document: HK

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20090506